Clinical Trial Update: A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT [Phase 3]

View source ↗

Summary

A Phase III trial comparing DE-117 ophthalmic solution to latanoprost for safety and efficacy in open-angle glaucoma or ocular hypertension has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-117
• Latanoprost (Latanoprost)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2024-03-15